1,2-dimethylhydrazine multiple interactions ISO RGD:1558001 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of HSPG2 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1558001 6480464 1, 2-Dimethylhydrazine results in increased expression of HSPG2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of HSPG2 mRNA CTD PMID:29097150 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of HSPG2 protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558001 6480464 Tetrachlorodibenzodioxin affects the expression of HSPG2 mRNA CTD PMID:16962184 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558001 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPG2 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1558001 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPG2 mRNA CTD PMID:15034205 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1558001 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of HSPG2 promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1558001 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of HSPG2 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO RGD:1558001 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of HSPG2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1558001 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with LIF protein] results in decreased expression of HSPG2 mRNA, [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of HSPG2 mRNA CTD PMID:30951980 7,12-dimethyltetraphene affects expression ISO RGD:1558001 6480464 9 more ... CTD PMID:21785161 acrylamide decreases expression ISO RGD:1351428 6480464 Acrylamide results in decreased expression of HSPG2 mRNA CTD PMID:32763439 aflatoxin B1 affects methylation ISO RGD:1351428 6480464 Aflatoxin B1 affects the methylation of HSPG2 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1351428 6480464 aflatoxin B2 results in increased methylation of HSPG2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1351428 6480464 Tretinoin results in increased expression of HSPG2 mRNA CTD PMID:17138961 all-trans-retinoic acid decreases expression ISO RGD:1351428 6480464 Tretinoin results in decreased expression of HSPG2 mRNA CTD PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:1558001 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of HSPG2 mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of HSPG2 mRNA CTD PMID:30951980 antirheumatic drug increases expression ISO RGD:1351428 6480464 Antirheumatic Agents results in increased expression of HSPG2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1351428 6480464 aristolochic acid I results in decreased expression of HSPG2 protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1351428 6480464 arsenite inhibits the reaction [G3BP1 protein binds to HSPG2 mRNA] CTD PMID:32406909 aspartame multiple interactions ISO RGD:1558001 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HSPG2 mRNA CTD PMID:23783067 benzo[a]pyrene affects expression ISO RGD:1558001 6480464 Benzo(a)pyrene affects the expression of HSPG2 mRNA CTD PMID:22342234 benzo[a]pyrene increases expression ISO RGD:1351428 6480464 Benzo(a)pyrene results in increased expression of HSPG2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1351428 6480464 Benzo(a)pyrene affects the methylation of HSPG2 intron, Benzo(a)pyrene affects the methylation of HSPG2 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1558001 6480464 Benzo(a)pyrene results in decreased expression of HSPG2 mRNA CTD PMID:15034205 , PMID:21569818 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HSPG2 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1351428 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HSPG2 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HSPG2 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HSPG2 mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO RGD:1558001 6480464 [bisphenol A co-treated with LIF protein] results in decreased expression of HSPG2 mRNA CTD PMID:30951980 bisphenol A decreases methylation ISO RGD:1558001 6480464 bisphenol A results in decreased methylation of HSPG2 promoter CTD PMID:27312807 bisphenol A increases methylation ISO RGD:1558001 6480464 bisphenol A results in increased methylation of HSPG2 promoter CTD PMID:27312807 bisphenol F multiple interactions ISO RGD:1558001 6480464 [bisphenol F co-treated with LIF protein] results in decreased expression of HSPG2 mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of HSPG2 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:1558001 6480464 1, 3-butadiene results in decreased expression of HSPG2 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:1351428 6480464 butyraldehyde results in decreased expression of HSPG2 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1351428 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPG2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1351428 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPG2 mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO RGD:1351428 6480464 Caffeine results in decreased phosphorylation of HSPG2 protein CTD PMID:35688186 calcitriol increases expression ISO RGD:1351428 6480464 Calcitriol results in increased expression of HSPG2 mRNA CTD PMID:16002434 carbon nanotube decreases expression ISO RGD:1558001 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1351428 6480464 CGP 52608 promotes the reaction [RORA protein binds to HSPG2 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1558001 6480464 Chlordecone results in increased expression of HSPG2 mRNA CTD PMID:33711761 chromium(6+) affects expression ISO RGD:1558001 6480464 chromium hexavalent ion affects the expression of HSPG2 mRNA CTD PMID:28472532 clobetasol decreases expression ISO RGD:1558001 6480464 Clobetasol results in decreased expression of HSPG2 mRNA CTD PMID:27462272 copper atom multiple interactions ISO RGD:1558001 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HSPG2 mRNA CTD PMID:15467011 copper atom multiple interactions ISO RGD:1351428 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HSPG2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1351428 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HSPG2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1558001 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HSPG2 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:1351428 6480464 Copper Sulfate results in decreased expression of HSPG2 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of HSPG2 mRNA CTD PMID:26577399 dextran sulfate multiple interactions ISO RGD:1558001 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSPG2 mRNA CTD PMID:29950665 dicrotophos increases expression ISO RGD:1351428 6480464 dicrotophos results in increased expression of HSPG2 mRNA CTD PMID:28302478 dioxygen affects methylation ISO RGD:1558001 6480464 Oxygen deficiency affects the methylation of HSPG2 promoter CTD PMID:24205000 dioxygen increases expression ISO RGD:1558001 6480464 Oxygen deficiency results in increased expression of HSPG2 mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:1351428 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPG2 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1558001 6480464 Ethanol results in increased expression of HSPG2 mRNA CTD PMID:30319688 fenamidone increases expression ISO RGD:1558001 6480464 fenamidone results in increased expression of HSPG2 mRNA CTD PMID:27029645 folic acid decreases expression ISO RGD:1558001 6480464 Folic Acid results in decreased expression of HSPG2 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1558001 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of HSPG2 mRNA] CTD PMID:22206623 fulvestrant multiple interactions ISO RGD:1351428 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HSPG2 gene CTD PMID:31601247 genistein decreases expression ISO RGD:1351428 6480464 Genistein results in decreased expression of HSPG2 mRNA CTD PMID:26865667 haloperidol decreases expression ISO RGD:1558001 6480464 Haloperidol results in decreased expression of HSPG2 mRNA CTD PMID:20072119 haloperidol multiple interactions ISO RGD:1558001 6480464 HSPG2 gene results in increased susceptibility to [Haloperidol co-treated with Reserpine] CTD PMID:20072119 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of HSPG2 mRNA CTD PMID:16771604 isoprenaline decreases expression ISO RGD:1558001 6480464 Isoproterenol results in decreased expression of HSPG2 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:1351428 6480464 Ivermectin results in decreased expression of HSPG2 protein CTD PMID:32959892 methamphetamine increases expression ISO RGD:1558001 6480464 Methamphetamine results in increased expression of HSPG2 mRNA CTD PMID:26307267 methotrexate increases expression ISO RGD:1351428 6480464 Methotrexate results in increased expression of HSPG2 mRNA CTD PMID:24449571 miconazole decreases expression ISO RGD:1558001 6480464 Miconazole results in decreased expression of HSPG2 mRNA CTD PMID:27462272 monosodium L-glutamate multiple interactions ISO RGD:1558001 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HSPG2 mRNA CTD PMID:23783067 nickel sulfate decreases expression ISO RGD:1351428 6480464 nickel sulfate results in decreased expression of HSPG2 mRNA CTD PMID:22714537 obeticholic acid decreases expression ISO RGD:1351428 6480464 obeticholic acid results in decreased expression of HSPG2 mRNA CTD PMID:27939613 ozone multiple interactions ISO RGD:1558001 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HSPG2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of HSPG2 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1351428 6480464 Acetaminophen results in increased expression of HSPG2 mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of HSPG2 mRNA CTD PMID:32680482 pentachlorophenol increases expression ISO RGD:1558001 6480464 Pentachlorophenol results in increased expression of HSPG2 mRNA CTD PMID:23892564 perfluorohexanesulfonic acid increases expression ISO RGD:1351428 6480464 perfluorohexanesulfonic acid results in increased expression of HSPG2 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1351428 6480464 perfluorooctane sulfonic acid results in increased expression of HSPG2 mRNA CTD PMID:25812627 potassium chromate decreases expression ISO RGD:1351428 6480464 potassium chromate(VI) results in decreased expression of HSPG2 mRNA CTD PMID:22714537 quercetin decreases expression ISO RGD:1351428 6480464 Quercetin results in decreased expression of HSPG2 mRNA CTD PMID:20596804 reserpine multiple interactions ISO RGD:1558001 6480464 HSPG2 gene results in increased susceptibility to [Haloperidol co-treated with Reserpine] CTD PMID:20072119 resveratrol multiple interactions ISO RGD:1351428 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPG2 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO RGD:1351428 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPG2 mRNA CTD PMID:27188386 silicon dioxide affects secretion ISO RGD:1351428 6480464 Silicon Dioxide analog affects the secretion of HSPG2 protein CTD PMID:25895662 sodium arsenite increases expression ISO RGD:1351428 6480464 sodium arsenite results in increased expression of HSPG2 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO RGD:1351428 6480464 sodium arsenite results in decreased expression of HSPG2 mRNA CTD PMID:34032870 sodium fluoride decreases expression ISO RGD:1558001 6480464 Sodium Fluoride results in decreased expression of HSPG2 protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of HSPG2 mRNA CTD PMID:19281266 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of HSPG2 protein CTD PMID:19634143 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of HSPG2 protein] CTD PMID:19634143 tetrachloromethane decreases expression ISO RGD:1558001 6480464 Carbon Tetrachloride results in decreased expression of HSPG2 mRNA CTD PMID:25270620 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HSPG2 mRNA CTD PMID:17056239 titanium dioxide multiple interactions ISO RGD:1558001 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSPG2 mRNA CTD PMID:29950665 trichostatin A increases expression ISO RGD:1351428 6480464 trichostatin A results in increased expression of HSPG2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1351428 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPG2 mRNA CTD PMID:27188386 valproic acid increases methylation ISO RGD:1351428 6480464 Valproic Acid results in increased methylation of HSPG2 gene CTD PMID:29501571
